DNLI logo

Denali Therapeutics (DNLI) Total Expenses

Annual Total Expenses

$527.23 M
+$78.02 M+17.37%

December 31, 2023


Summary


Performance

DNLI Total Expenses Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherDNLIexpensesmetrics:

Quarterly Total Expenses

$123.19 M
+$6.59 M+5.66%

September 30, 2024


Summary


Performance

DNLI Quarterly Total Expenses Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherDNLIexpensesmetrics:

Total Expenses Formula

Total Expenses = Cost of Goods Sold + Operating Expenses + Non Operating Expenses

DNLI Total Expenses Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+17.4%+5.7%
3 y3 years+93.2%+6.5%
5 y5 years+200.4%+6.5%

DNLI Total Expenses Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+53.1%-21.0%+37.4%
5 y5-yearat high+119.8%-21.0%+97.3%
alltimeall timeat high+3061.0%-21.0%+522.9%

Denali Therapeutics Total Expenses History

DateAnnualQuarterly
Sep 2024
-
$123.19 M(+5.7%)
Jun 2024
-
$116.59 M(-11.8%)
Mar 2024
-
$132.25 M(-0.2%)
Dec 2023
$527.23 M(+17.4%)
$132.57 M(+15.2%)
Sep 2023
-
$115.06 M(-6.9%)
Jun 2023
-
$123.64 M(-20.7%)
Mar 2023
-
$155.96 M(+34.9%)
Dec 2022
$449.21 M(+30.4%)
$115.63 M(+4.1%)
Sep 2022
-
$111.05 M(-2.5%)
Jun 2022
-
$113.90 M(+4.8%)
Mar 2022
-
$108.64 M(+21.2%)
Dec 2021
$344.41 M(+26.2%)
$89.64 M(-1.4%)
Sep 2021
-
$90.88 M(+7.2%)
Jun 2021
-
$84.76 M(+7.1%)
Mar 2021
-
$79.14 M(+8.8%)
Dec 2020
$272.94 M
$72.74 M(+4.6%)
DateAnnualQuarterly
Sep 2020
-
$69.51 M(+3.6%)
Jun 2020
-
$67.12 M(+5.6%)
Mar 2020
-
$63.57 M(+1.8%)
Dec 2019
$239.86 M(+36.6%)
$62.43 M(-2.1%)
Sep 2019
-
$63.76 M(-4.8%)
Jun 2019
-
$66.96 M(+43.3%)
Mar 2019
-
$46.71 M(-8.3%)
Dec 2018
$175.53 M(+94.7%)
$50.95 M(+30.1%)
Sep 2018
-
$39.16 M(-33.7%)
Jun 2018
-
$59.03 M(+123.7%)
Mar 2018
-
$26.39 M(+12.1%)
Dec 2017
$90.14 M(+3.1%)
$23.54 M(+5.6%)
Sep 2017
-
$22.29 M(-1.2%)
Jun 2017
-
$22.57 M(+3.8%)
Mar 2017
-
$21.74 M(+10.0%)
Dec 2016
$87.43 M(+424.2%)
$19.78 M
Dec 2015
$16.68 M
-

FAQ

  • What is Denali Therapeutics annual total expenses?
  • What is the all time high annual total expenses for Denali Therapeutics?
  • What is Denali Therapeutics annual total expenses year-on-year change?
  • What is Denali Therapeutics quarterly total expenses?
  • What is the all time high quarterly total expenses for Denali Therapeutics?
  • What is Denali Therapeutics quarterly total expenses year-on-year change?

What is Denali Therapeutics annual total expenses?

The current annual total expenses of DNLI is $527.23 M

What is the all time high annual total expenses for Denali Therapeutics?

Denali Therapeutics all-time high annual total expenses is $527.23 M

What is Denali Therapeutics annual total expenses year-on-year change?

Over the past year, DNLI annual total expenses has changed by +$78.02 M (+17.37%)

What is Denali Therapeutics quarterly total expenses?

The current quarterly total expenses of DNLI is $123.19 M

What is the all time high quarterly total expenses for Denali Therapeutics?

Denali Therapeutics all-time high quarterly total expenses is $155.96 M

What is Denali Therapeutics quarterly total expenses year-on-year change?

Over the past year, DNLI quarterly total expenses has changed by +$6.59 M (+5.66%)